Search - tctmd.com

Displaying 181 - 200 of 555

Sort: Relevancy | Date

Presentation TCT 2018

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

Presenter: Joseph E. Bavaria, Horst Sievert, Hasan Jilaihawi

September 22, 2018

Presentation TCT 2018

A Structural Interventionalist Perspective on BAV Treatment: The Next TAVR Frontier Almost All Patients are TAVR Candidates

Presenter: Joseph E. Bavaria, Horst Sievert, Mathew Williams

September 22, 2018

Presentation TCT 2018

A CT Imaging Perspective on BAV Treatment: Which Patients are Poor Candidates for TAVR

Presenter: Joseph E. Bavaria, Horst Sievert, Jonathon A. Leipsic

September 22, 2018

Presentation TCT 2018

A Surgeons Perspective on BAV Treatment: Why Surgery is Preferred in Many (Most) BAV Patients

Presenter: Joseph E. Bavaria, Horst Sievert

September 22, 2018

Presentation TCT 2018

TCT-100: Emergency TAVR for Cardiogenic ShockRight Heart Function and Early Mechanical Circulatory Support Improve Outcomes

Presenter: Alain G. Cribier, Helene Eltchaninoff, Creighton Don

September 21, 2018

Presentation TCT 2018

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

Presenter: Alain G. Cribier, Helene Eltchaninoff, Herbert Kroon

September 21, 2018

Presentation TCT 2018

TCT-97: Preserving Coronary Access After Valve-in-TAVI: A Glimpse Into the Future

Presenter: Alain G. Cribier, Helene Eltchaninoff, Nicola Buzzatti

September 21, 2018

Presentation TCT 2018

TCT-88: Optimal Cerebral Protection in Cardiac and Aortic Interventions: Vascular Filters vs. Balloon Occlusion?

Presenter: Jacques Busquet, Virendra I Patel, Michael Zhadkevich

September 21, 2018

Presentation TCT 2018

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

Presenter: Alex Chebl, Alexandra J. Lansky, Liang Tang

September 21, 2018

Presentation TCT 2018

TCT-87: Thirty-Day Readmission Rate & Etiologies after Endovascular Repair of Abdominal Aortic Aneurysm: A Nationwide Analysis

Presenter: Jacques Busquet, Virendra I Patel, Varunsiri Atti

September 21, 2018

Presentation TCT 2018

TCT-71: Predictors, Incidence and Outcomes of Patients Undergoing Transcatheter Aortic Valve Implantation Complicated by Stroke From the CENTER-Collaboration

Presenter: Alex Chebl, Alexandra J. Lansky, Wieneke Vlastra

September 21, 2018

Presentation TCT 2018

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Presenter: Alex Chebl, Alexandra J. Lansky, Chetan Huded

September 21, 2018

Presentation TCT 2018

Case Conclusion

Presenter: Sarah Clarke, Kim Guibone, Marian C. Hawkey, Sandra Lauck

September 21, 2018

Presentation TCT 2018

TCT-69: Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration

Presenter: Alex Chebl, Alexandra J. Lansky, Stephanie Sellars

September 21, 2018

Presentation TCT 2018

Individualizing the Patient Care Pathway

Presenter: Sarah Clarke, Sandra Lauck

September 21, 2018

Presentation TCT 2018

TCT-60: Stent Treatment of Branch Pulmonary Artery Stenosis in Children With Congenital Heart Disease After Cardiac Surgery

Presenter: Shao-Liang Chen, Mitchell Weinberg, Saule Kadirova

September 21, 2018

Presentation TCT 2018

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

Presenter: David Hildick-Smith, Martin B. Leon, Giuseppe Biondi-Zoccai

September 21, 2018

Presentation TCT 2018

Current Indications and Guidelines for TAVR

Presenter: Sarah Clarke, Kim Guibone

September 21, 2018

Presentation TCT 2018

Case Introduction: Aortic Stenosis

Presenter: Sarah Clarke, Kim Guibone, Marian C. Hawkey, Sandra Lauck

September 21, 2018

Presentation TCT 2018

InSeal Closure Device: Post CE Experience in TAVR and EVAR Procedures

Presenter: Hendrik Ruge

September 21, 2018

Advertisement

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

A Structural Interventionalist Perspective on BAV Treatment: The Next TAVR Frontier Almost All Patients are TAVR Candidates

A CT Imaging Perspective on BAV Treatment: Which Patients are Poor Candidates for TAVR

A Surgeons Perspective on BAV Treatment: Why Surgery is Preferred in Many (Most) BAV Patients

TCT-100: Emergency TAVR for Cardiogenic ShockRight Heart Function and Early Mechanical Circulatory Support Improve Outcomes

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

TCT-97: Preserving Coronary Access After Valve-in-TAVI: A Glimpse Into the Future

TCT-88: Optimal Cerebral Protection in Cardiac and Aortic Interventions: Vascular Filters vs. Balloon Occlusion?

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

TCT-87: Thirty-Day Readmission Rate & Etiologies after Endovascular Repair of Abdominal Aortic Aneurysm: A Nationwide Analysis

TCT-71: Predictors, Incidence and Outcomes of Patients Undergoing Transcatheter Aortic Valve Implantation Complicated by Stroke From the CENTER-Collaboration

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Case Conclusion

TCT-69: Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration

Individualizing the Patient Care Pathway

TCT-60: Stent Treatment of Branch Pulmonary Artery Stenosis in Children With Congenital Heart Disease After Cardiac Surgery

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

Current Indications and Guidelines for TAVR

Case Introduction: Aortic Stenosis

InSeal Closure Device: Post CE Experience in TAVR and EVAR Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content